These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 383105

  • 1. [Summary of the podium discussion on the fundamentals and guidelines for preliminary clinical trials of psychopharmaceutics (phase I and II) Oct. 29, 1977].
    Heimann H.
    Arzneimittelforschung; 1978; 28(9):1534-6. PubMed ID: 383105
    [No Abstract] [Full Text] [Related]

  • 2. [Principles and regulations for clinical pilot studies on psycholeptic drugs (author's transl)].
    Woggon B, Angst J.
    Arzneimittelforschung; 1978; 28(8):1257-9. PubMed ID: 380573
    [Abstract] [Full Text] [Related]

  • 3. [Difficulties of a clinician in planning psychopharmacological trials (author's transl)].
    Woggon B.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):140-6. PubMed ID: 360238
    [Abstract] [Full Text] [Related]

  • 4. Time-blind analysis and other video-strategies in phase II trials of psychotropic drugs.
    Müller-Oerlinghausen B, Renfordt E.
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):99-103. PubMed ID: 7380587
    [Abstract] [Full Text] [Related]

  • 5. Time-blind evaluation of psychopathology in drug research.
    Bobon DP.
    Acta Psychiatr Belg; 1978 Mar; 78(4):635-45. PubMed ID: 362829
    [Abstract] [Full Text] [Related]

  • 6. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract] [Full Text] [Related]

  • 7. [Statistical aspects in planning psychotropic drug trials (author's transl)].
    Ferner U.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):132-9. PubMed ID: 360237
    [Abstract] [Full Text] [Related]

  • 8. Panel discussion on clinical trials: design.
    Forssman L.
    Rheumatol Rehabil; 1978 May; Suppl():126-8. PubMed ID: 364603
    [No Abstract] [Full Text] [Related]

  • 9. Guidelines for clinical trials of psychotropic drugs June 1, 1977.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Jul; 10(4):205-31. PubMed ID: 360242
    [No Abstract] [Full Text] [Related]

  • 10. [Effectiveness of non-steroidal anti-inflammatory and psychotropic drugs in patients with rheumatoid arthritis].
    Korshunov NI, Baranova EIa.
    Ter Arkh; 1984 Jul; 56(11):77-81. PubMed ID: 6395430
    [Abstract] [Full Text] [Related]

  • 11. [The AMDP scales in a phase II evaluation of psychotropic drugs].
    Digonnet C, Boyer P, Puech AJ, von Frenckell R, Weil JS.
    Acta Psychiatr Belg; 1987 Jul; 87(2):245-52. PubMed ID: 3618275
    [Abstract] [Full Text] [Related]

  • 12. Improvement of phase III psychotropic drug trials by intensive phase II work.
    Klein DF.
    Neuropsychopharmacology; 1991 Jun; 4(4):251-8; discussion 259-71. PubMed ID: 1867735
    [Abstract] [Full Text] [Related]

  • 13. [Methodological and theoretical aspects of the evaluation of psychotropic drugs in normal healthy volunteers (author's transl)].
    Debus G.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):109-18. PubMed ID: 360235
    [Abstract] [Full Text] [Related]

  • 14. [Editorial: Clinical testing of new psychopharmaceutics. Is it time for coordinated achievements?].
    Perris C.
    Lakartidningen; 1976 Apr 07; 73(15):1395-6. PubMed ID: 1263654
    [No Abstract] [Full Text] [Related]

  • 15. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).
    Pharmacopsychiatria; 1981 Sep 07; 14(5):190-9. PubMed ID: 7291302
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacotherapy and psychotherapy: paradoxes problems and progress. Formulated by the Committee on Research.
    Rep Group Adv Psychiatry; 1975 Mar 07; 9(93):263-434. PubMed ID: 1092600
    [No Abstract] [Full Text] [Related]

  • 17. Double-blinding in clinical trials.
    Ney PG.
    CMAJ; 1989 Jan 01; 140(1):15. PubMed ID: 2909265
    [No Abstract] [Full Text] [Related]

  • 18. Clinical factors that may confound the assessment of drug efficacy.
    Csernansky JG, Newcomer JW, Miller LS, Faustman WO.
    Psychopharmacol Bull; 1991 Jan 01; 27(3):231-5. PubMed ID: 1775593
    [Abstract] [Full Text] [Related]

  • 19. Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning.
    Gainotti G, Benedetti N, Caltagirone C, Nocentini U.
    Clin Neuropharmacol; 1986 Jan 01; 9 Suppl 3():S65-9. PubMed ID: 3297320
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of psychotropic drugs].
    Nieto D.
    Bol Estud Med Biol; 1974 Jan 01; Suppl 1():309-17. PubMed ID: 4619018
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.